Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07213947 · ClinicalTrials.gov registry record · NA
Comparison of Demand and Substitution for Nicotine Pouches as a Function of Nicotine Dosage
A NA study of Tobacco Use and Nicotine Pouch Self-Administration, sponsored by William Middleton.
- Completed
- Registry status
- NA
- Development phase
- 1,360
- Enrollment target
- 1
- Study location
NCT07213947: Completed NA study of Tobacco Use and Nicotine Pouch Self-Administration, sponsored by William Middleton.
NCT07213947 is a NA study of Tobacco Use and Nicotine Pouch Self-Administration that has completed, run by William Middleton. The registered enrollment target is 1,360 participants, above the 361-participant average among 76 other Tobacco Use trials with a reported enrollment target (277% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07213947, a NA study of Tobacco Use and Nicotine Pouch Self-Administration, has completed, sponsored by William Middleton.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,360 participants
- Enrollment target
- 1
- Study location
Study Summary
Smoking is a prominent public health issue. Traditional nicotine replacement therapy suffers from being a poor substitute for cigarettes. Novel tobacco products, such as nicotine pouches, show promise as potential low-harm substitutes. Investigators wish to assess the substitutability of cigarettes for nicotine pouches at different dosages and price points. This study will consist of 4000 screened participants online on the crowdsourcing software Prolific, with roughly 400 eligible participants. This study will include the use of an electronic tobacco marketplace.
Primary Outcome
Behavioral demand curves will be drawn for nicotine pouch consumption as a function of price. Demand curves will be compared across dosage conditions on three indices: breakpoint (price at which consumption drops to zero) , elasticity of demand (rate of decline of consumption at any price), and intensity of demand (consumption at zero price).
Conditions Studied
Interventions
- OTHER Nicotine Pouch Dosage
Study Locations (1)
Kentucky
- University of Kentucky Turfland Medical Center, Department of Family and Community Medicine - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,360 participants |
| Start Date | 2025-12-04 |
| Est. Completion | 2026-01-02 |
| Phase | NA |
What the finished NCT07213947 record still lists
NCT07213947 is an interventional study that assigns participants to a tested intervention. Its 1,360 participants enrollment target places it among the larger protocols in the corpus, above the 361-participant average among 76 other Tobacco Use trials with a reported enrollment target (277% higher).
The record links to 2 conditions, with Tobacco Use appearing as the primary indexed condition, and to 1 intervention - of which Nicotine Pouch Dosage is the first listed.
NCT07213947 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT07213947 about?
NCT07213947 is a clinical study titled "Comparison of Demand and Substitution for Nicotine Pouches as a Function of Nicotine Dosage". Smoking is a prominent public health issue. Traditional nicotine replacement therapy suffers from being a poor substitute for cigarettes. Novel tobacco products, such as nicotine pouches, show promise as potential low-harm substitutes. Investigators wish to assess the substitutability of cigarettes ...
What is the current status of trial NCT07213947?
This trial is currently completed. It is a NA study. The enrollment target is 1,360 participants. The study started on 2025-12-04. Estimated completion is 2026-01-02.
What conditions does trial NCT07213947 study?
This clinical trial studies the following conditions: Tobacco Use, Nicotine Pouch Self-Administration.
What interventions are being tested in trial NCT07213947?
The interventions under investigation include: Nicotine Pouch Dosage (OTHER).
Who is sponsoring clinical trial NCT07213947?
This trial is sponsored by William Middleton, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07213947 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07213947's enrollment target sits among peer trials
1,360 6th of 76 higher than 71 of 76 other Tobacco Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tobacco Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chronic Reflux
RECRUITING · NA
-
Opioids, Low Nicotine Cigarettes, and Chronic Pain
RECRUITING · NA
-
Reach Through Equitable Implementation in Utah
RECRUITING · NA
-
RTMS Targets Neural Circuits for Smoking Cessation
RECRUITING · NA
-
Cigar Legislation and Regulation in Tobacco for the Young (Project CLARITY)
RECRUITING · NA
-
Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05245227 · 1,358 participants · Phase 3
Double Simultaneous Uterotonic Agents Versus Single Agent Regimen to Prevent Early Postpartum Hemorrhage
- NCT02677064 · 1,365 participants
Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia
- NCT04489238 · 1,366 participants
Collection of Information to Better Understand Young Onset Colorectal Cancer
- NCT07256392 · 1,370 participants · Phase 3
Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI